EPISODE · Mar 30, 2026 · 5 MIN
今天3分钟我们来聊聊晚期宫颈癌新希望：TIL细胞治疗亚洲案例
from 源于细胞BioInsid的个人播客
宫颈癌高发，晚期患者传统治疗效果差。最新研究中，自体TIL细胞治疗让2例亚洲晚期宫颈癌患者肿瘤快速缩小。TIL如精准特种兵，提取、扩增、回输三步起效，为无药可用患者带来新选择，但存在成功率、成本等挑战。前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊晚期宫颈癌新希望：TIL细胞治疗亚洲案例
0:00
5:09
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 5 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on March 30, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!